Antibacterial activity of bupivacaine alone and combined with S-ketamine against bacteria causing catheter-associated infections (CROSBI ID 597047)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Mihaljević, Ljiljana ; Bedenić, Branka ; Mihaljević, Slobodan ; Vraneš, Jasmina ; Varda-Brkić, Dijana ; Meštrović, Tomislav
engleski
Antibacterial activity of bupivacaine alone and combined with S-ketamine against bacteria causing catheter-associated infections
Several of the local anaesthetics used for spinal anaesthesia were shown to possess antibacterial activity. The study was undertaken to evaluate the antibacterial effect of bupivacain alone and combined with S-ketamine on seven different microorganisms. The microorganisms tested were: Staphylococcus aureus ATCC 25923, Staphylococcus epidermidis, methicillin-resistant S. aureus, Enterococcus faecalis ATCC 29212, Escherichia coli 29212, Pseudomonas aeruginosa ATCC 27853 and Acinetobacter baumannii 19091. Bacteridical effect of bupivacaine was tested in concentrations of 0.5, 0.25 and 0.12%. The bactericidal activity was determined by standard microbiological methods. The number of colonyforming unit (CFU) was counted and the number of viable bacteria was plotted against time to obtain a time-kill curve. Anaesthetic was considered to possess antimicrobial activity when a significant difference in CFU/ml (1log10) was observed between the initial and postexposure values. Bupivacaine with and without Sketamine significantly reduced (2 to 4 log10) the CFU of S. aureus , S. epidermidis and E. faecalis in all concentrations. The reduction of viable counts was more pronounced with higher concentration of anaesthetic and after additionof S-ketamine. With MRSA significant reduction of viable counts was observed only with 0.5% of bupivacaine. Against A. baumannii bupivacain produced a small (1 log10) but significant reduction in viable count number in concentration of 0.5 and 0.25% but when combined with S-ketamine the reduction was more pronounced (1 log10 to 4 log10) in all concentrations. Bupivacaine exerted significant bactericial activity against P. aeruginosa only in the highest concentration. Addition of S-ketamine did not improve antibacterial activity. E. coli exhibited strong and significant decrease in viable counts after exposure to bupivacaine. In this study, the antimicrobial effect of bupivacaine in various concentrations alone and combined with S-ketamine was studied. Significant antibacterial effect of bupivacain alone and combined with S-ketamine was noticed in all tested bacteria except of P. aeruginosa. Addition of S-ketamine enhanced the antibacterial acitivtity of bupivacaine. Antibacterial acitivity of bupivacaine was concentration dependent and timedependent. Bactericidal activity of local anaesthetic could prevent infection in patients with indwelling catheters.
Catheter-associated infections ; local anaesthetics ; antibacterial activity
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
xx-xx.
2013.
objavljeno
Podaci o matičnoj publikaciji
Abstracts of the 23rd European Congress of Clinical Microbiology and Infection Diseases : proceedings
Podaci o skupu
European Congress of Clinical Microbiology and Infection Diseases (23 ; 2013)
ostalo
27.04.2013-30.04.2013
Berlin, Njemačka